Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02880137 · ClinicalTrials.gov registry record · Phase 4
Real Time Myocardial Perfusion Echocardiography for Coronary Allograft Vasculopathy
A Phase 4 study of Cardiac Allograft Vasculopathy, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 36
- Enrollment target
- 1
- Study location
NCT02880137 is a Phase 4 study of Cardiac Allograft Vasculopathy that has completed, run by Mayo Clinic. The registered enrollment target is 36 participants, below the 119-participant average among 3 other Cardiac Allograft Vasculopathy trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02880137, a Phase 4 study of Cardiac Allograft Vasculopathy, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
Is real-time myocardial perfusion echocardiography (RTMPE) a feasible and effective non-invasive method to detect significant Coronary Allograft Vasculopathy in pediatric and adult cardiac transplant recipients? Will perfusion deficits correlate with significant coronary artery stenosis identified by standard stress echocardiography and Invasive Coronary Angiography (ICA), and identify diffuse small vessel disease more effectively than current non-invasive techniques?
Conditions Studied
Interventions
- DRUG Perflutren Lipid Microsphere
- PROCEDURE RTMPE
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2016-09 |
| Est. Completion | 2018-06-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02880137
The ClinicalTrials.gov registry entry for NCT02880137 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 119-participant average among 3 other Cardiac Allograft Vasculopathy trials with a reported enrollment target (70% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cardiac Allograft Vasculopathy appearing as the primary indexed condition, and to 2 interventions - of which Perflutren Lipid Microsphere is the first listed.
NCT02880137 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT02880137 about?
NCT02880137 is a clinical study titled "Real Time Myocardial Perfusion Echocardiography for Coronary Allograft Vasculopathy". Is real-time myocardial perfusion echocardiography (RTMPE) a feasible and effective non-invasive method to detect significant Coronary Allograft Vasculopathy in pediatric and adult cardiac transplant recipients? Will perfusion deficits correlate with significant coronary artery stenosis identified b...
What is the current status of trial NCT02880137?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 36 participants. The study started on 2016-09. Estimated completion is 2018-06-30.
What conditions does trial NCT02880137 study?
This clinical trial studies the following conditions: Cardiac Allograft Vasculopathy.
What interventions are being tested in trial NCT02880137?
The interventions under investigation include: Perflutren Lipid Microsphere (DRUG), RTMPE (PROCEDURE).
Who is sponsoring clinical trial NCT02880137?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02880137 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiac Allograft Vasculopathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Optical Coherence Tomography (OCT) to Evaluate Cardiac Allograft Vasculopathy (CAV) in Patient's Post Heart Transplant
COMPLETED
-
Angiotensin Converting Enzyme (ACE) Inhibition and Cardiac Allograft Vasculopathy
COMPLETED · NA
-
A P2X7R Single Nucleotide Mutation Promotes Chronic Allograft Vasculopathy
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.